News
AM-001 Study represents a pivotal milestone in Galmed's transition to Aramchol Meglumine, an improved formulation of its lead compound in advanced clinical development – Aramchol Meglumine ...
(RTTNews) - Galmed Pharmaceuticals (GLMD) announced positive preliminary results from Part 1 of the Ph1 Bioavailability AM-001 Study of Aramchol Meglumine. The company said initial findings ...
A CT scan of the abdomen can show the organs, blood vessels, and bones in your abdominal cavity. The multiple images provided by the scan can give your doctor many different views of your body. A ...
UMD Professor of Cell Biology and Molecular Genetics Najib El-Sayed, co-lead author of the study, noted that the standard drug used to treat the disease—meglumine antimoniate—typically fails ...
The team found that patients who failed to respond to meglumine antimoniate showed a distinctive pattern in their immune system, a sustained inflammatory state called a type I interferon response.
A magnificent pathway seems to exist between the brain and heart culminating in mast cell activation and development of Kounis syndrome (Figure 2). Depressogenic stress impulses arising from high ...
The total population also included patients also being treated with Pfizer’s blockbuster ATTR-cardiomyopathy drug Vyndamax (tafamidis meglumine) at baseline, and vutrisiran performed even better ...
At close: April 22 at 4:00:00 PM EDT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results